Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);骨形态发生蛋白质7(Bone Morphogenetic Protein 7);细胞系, 肿瘤(Cell Line, Tumor);胶原Ⅰ型(Collagen Type I);药物评价, 临床前(Drug Evaluation, Preclinical);基因表达调控(Gene Expression Regulation);特发性肺纤维化(Idiopathic Pulmonary Fibrosis);分化抑制蛋白质类(Inhibitor of Differentiation Proteins);小鼠(Mice);肿瘤蛋白质类(Neoplasm Proteins);信号传导(Signal Transduction);替洛隆(Tilorone)
DOI
10.1165/rcmb.2012-0201OC
PMID
23258233
发布时间
2021-12-03
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文